Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Staudt

Showing results (231-240 of 434) with videos related to

Pageof 44
Sort By:
Cancer Research|December 1, 2018
TLR Signaling Is Activated in Lymph Node-Resident CLL Cells and Is Only Partially Inhibited by IbrutinibEman L Dadashian, Erin M McAuley, Delong Liu, et al.
Oncogene|January 16, 2013
Loss-of-function screen in rhabdomyosarcoma identifies CRKL-YES as a critical signal for tumor growthC L Yeung, V N Ngo, P J Grohar, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 5, 2020
Regulation of B cell receptor-dependent NF-κB signaling by the tumor suppressor KLHL14Jaewoo Choi, James D Phelan, George W Wright, et al.
The Journal of Trauma and Acute Care Surgery|July 3, 2023
Finding the bleeding edge: 24-hour mortality by unit of blood product transfused in combat casualties from 2002-2020Jennifer M Gurney, Amanda M Staudt, John B Holcomb, et al.
British Journal of Haematology|June 16, 2025
The anti-CD47 antibody magrolimab with obinutuzumab and venetoclax in relapsed or refractory indolent B-cell lymphomasRahul Lakhotia, Christopher Melani, Stefania Pittaluga, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 6, 2007
Characterization of early stages of human B cell development by gene expression profilingMarit E Hystad, June H Myklebust, Trond H Bø, et al.
Blood Neoplasia|June 23, 2025
A phase 1 study of interleukin-15 in combination with mogamulizumab in relapsed and refractory T-cell malignanciesMax J Gordon, Sigrid Dubois, Milos D Miljkovic, et al.
Cell|November 30, 2007
Ribosomal protein S3: a KH domain subunit in NF-kappaB complexes that mediates selective gene regulationFengyi Wan, D Eric Anderson, Robert A Barnitz, et al.
Clinical Advances in Hematology & Oncology : H&O|October 15, 2005
Linking laboratory and clinical research: the development of molecularly targeted therapeutics inside the national cancer institute center for cancer researchJ Carl Barrett, L Michelle Bennett, Laura Kay Fleming, et al.
The Journal of Trauma and Acute Care Surgery|May 12, 2022
Determining resuscitation outcomes in combat casualties: Design of the Deployed Hemostatic Emergency Resuscitation of Traumatic Exsanguinating Shock (Deployed HEROES) studyJennifer M Gurney, Amanda M Staudt, Deborah J Del Junco, et al.
Pageof 44

Showing results (231-240 of 434) with videos related to

Sort By:
Pageof 44
Cancer Research|December 1, 2018
TLR Signaling Is Activated in Lymph Node-Resident CLL Cells and Is Only Partially Inhibited by IbrutinibEman L Dadashian, Erin M McAuley, Delong Liu, et al.
Oncogene|January 16, 2013
Loss-of-function screen in rhabdomyosarcoma identifies CRKL-YES as a critical signal for tumor growthC L Yeung, V N Ngo, P J Grohar, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 5, 2020
Regulation of B cell receptor-dependent NF-κB signaling by the tumor suppressor KLHL14Jaewoo Choi, James D Phelan, George W Wright, et al.
The Journal of Trauma and Acute Care Surgery|July 3, 2023
Finding the bleeding edge: 24-hour mortality by unit of blood product transfused in combat casualties from 2002-2020Jennifer M Gurney, Amanda M Staudt, John B Holcomb, et al.
British Journal of Haematology|June 16, 2025
The anti-CD47 antibody magrolimab with obinutuzumab and venetoclax in relapsed or refractory indolent B-cell lymphomasRahul Lakhotia, Christopher Melani, Stefania Pittaluga, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 6, 2007
Characterization of early stages of human B cell development by gene expression profilingMarit E Hystad, June H Myklebust, Trond H Bø, et al.
Blood Neoplasia|June 23, 2025
A phase 1 study of interleukin-15 in combination with mogamulizumab in relapsed and refractory T-cell malignanciesMax J Gordon, Sigrid Dubois, Milos D Miljkovic, et al.
Cell|November 30, 2007
Ribosomal protein S3: a KH domain subunit in NF-kappaB complexes that mediates selective gene regulationFengyi Wan, D Eric Anderson, Robert A Barnitz, et al.
Clinical Advances in Hematology & Oncology : H&O|October 15, 2005
Linking laboratory and clinical research: the development of molecularly targeted therapeutics inside the national cancer institute center for cancer researchJ Carl Barrett, L Michelle Bennett, Laura Kay Fleming, et al.
The Journal of Trauma and Acute Care Surgery|May 12, 2022
Determining resuscitation outcomes in combat casualties: Design of the Deployed Hemostatic Emergency Resuscitation of Traumatic Exsanguinating Shock (Deployed HEROES) studyJennifer M Gurney, Amanda M Staudt, Deborah J Del Junco, et al.
Pageof 44